Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to -$739.2 million.

  • Fresenius Medical Care AG's Net Income towards Common Stockholders rose 2558.74% to -$739.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 billion, marking a year-over-year increase of 636.01%. This contributed to the annual value of $574.8 million for FY2024, which is 706.3% up from last year.
  • According to the latest figures from Q3 2025, Fresenius Medical Care AG's Net Income towards Common Stockholders is -$739.2 million, which was up 2558.74% from -$1.2 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Net Income towards Common Stockholders ranged from a high of -$739.2 million in Q3 2025 and a low of -$1.6 billion during Q4 2022
  • Over the past 5 years, Fresenius Medical Care AG's median Net Income towards Common Stockholders value was -$1.2 billion (recorded in 2025), while the average stood at -$1.2 billion.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 3844.99% in 2021, then surged by 3627.96% in 2023.
  • Fresenius Medical Care AG's Net Income towards Common Stockholders (Quarter) stood at -$1.4 billion in 2021, then dropped by 10.86% to -$1.6 billion in 2022, then surged by 36.28% to -$1.0 billion in 2023, then fell by 12.24% to -$1.1 billion in 2024, then skyrocketed by 35.59% to -$739.2 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$739.2 million for Q3 2025, versus -$1.2 billion for Q2 2025 and -$992.4 million for Q1 2025.